BEGIN:VCALENDAR
VERSION:2.0
PRODID:researchseminars.org
CALSCALE:GREGORIAN
X-WR-CALNAME:researchseminars.org
BEGIN:VEVENT
SUMMARY:Peter Kharchenko (Harvard University)
DTSTART:20210503T141000Z
DTEND:20210503T144000Z
DTSTAMP:20260422T212827Z
UID:ComputationalBiology/1
DESCRIPTION:Title: <a href="https://researchseminars.org/talk/Computationa
 lBiology/1/">Bayesian segmentation of spatially resolved transcriptomics d
 ata</a>\nby Peter Kharchenko (Harvard University) as part of Computational
  Biology Symposium\n\n\nAbstract\nSpatial transcriptomics is an emerging s
 tack of technologies\, which adds spatial dimension to conventional single
 -cell RNA-sequencing. New protocols\, based on in situ sequencing or multi
 plexed RNA fluorescent in situ hybridization register positions of single 
 molecules in fixed tissue slices. Analysis of such data at the level of in
 dividual cells\, however\, requires accurate identification of cell bounda
 ries. While many existing methods are able to approximate cell center posi
 tions using nuclei stains\, current protocols do not report robust signal 
 on the cell membranes\, making accurate cell segmentation a key barrier fo
 r downstream analysis and interpretation of the data. To address this chal
 lenge\, we developed a tool for Bayesian Segmentation of Spatial Transcrip
 tomics Data (Baysor)\, which optimizes segmentation considering the likeli
 hood of transcriptional composition\, size and shape of the cell. The Baye
 sian approach can take into account nuclear or cytoplasm staining\, howeve
 r can also perform segmentation based on the detected transcripts alone. W
 e show that Baysor segmentation can in some cases nearly double the number
  of the identified cells\, while reducing contamination. Importantly\, we 
 demonstrate that Baysor performs well on data acquired using five differen
 t spatially-resolved protocols\, making it a useful general tool for analy
 sis of high-resolution spatial data.\n
LOCATION:https://researchseminars.org/talk/ComputationalBiology/1/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Smita Krishnaswamy (Yale University)
DTSTART:20210503T144500Z
DTEND:20210503T151500Z
DTSTAMP:20260422T212827Z
UID:ComputationalBiology/2
DESCRIPTION:Title: <a href="https://researchseminars.org/talk/Computationa
 lBiology/2/">Geometric and Topological Approaches to Representation Learni
 ng in Biomedical Data</a>\nby Smita Krishnaswamy (Yale University) as part
  of Computational Biology Symposium\n\n\nAbstract\nHigh-throughput\, high-
 dimensional data has become ubiquitous in the biomedical\, health and soci
 al sciences as a result of breakthroughs in measurement technologies and d
 ata collection. While these large datasets containing millions of observat
 ions of cells\, peoples\, or brain voxels  hold great potential for unders
 tanding generative state space of the data\, as well as drivers of differe
 ntiation\, disease and progression\, they also pose new challenges in term
 s of noise\, missing data\, measurement artifacts\, and the so-called “c
 urse of dimensionality.” In this talk\, I will cover data geometric and 
 topological approaches to understanding the shape and structure of the dat
 a.  First\, we show how diffusion geometry and deep learning can be  used 
 to obtain useful representations of the data that enable denoising (MAGIC)
 \, dimensionality reduction (PHATE)\, and factor analysis (Archetypal Anal
 ysis Network) of the data.  Next we will show how to learn dynamics from s
 tatic snapshot data by using a manifold-regularized neural ODE-based optim
 al transport (TrajectoryNet). Finally\, we cover a novel approach to combi
 ne diffusion geometry with topology to extract multi-granular features fro
 m the data (Diffusion Condensation and Multiscale PHATE) to assist in diff
 erential and predictive analysis. On the flip side\, we also create a mani
 fold geometry from topological descriptors\, and show its applications to 
 neuroscience. Together\, we will show a complete framework for exploratory
  and unsupervised analysis of big biomedical data.\n
LOCATION:https://researchseminars.org/talk/ComputationalBiology/2/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Meromit Singer (Harvard Medical School)
DTSTART:20210503T152000Z
DTEND:20210503T155000Z
DTSTAMP:20260422T212827Z
UID:ComputationalBiology/3
DESCRIPTION:Title: <a href="https://researchseminars.org/talk/Computationa
 lBiology/3/">Utilizing coupled single-cell RNA-seq and TCR-seq to reveal T
 h17 systemic dynamics during homeostasis and disease</a>\nby Meromit Singe
 r (Harvard Medical School) as part of Computational Biology Symposium\n\n\
 nAbstract\nIn this talk we will describe a systemic study of the transcrip
 tional and clonal characteristics and function of Th17 cells throughout mu
 ltiple mouse organs\, as revealed by coupled single-cell RNA-seq and TCR-s
 eq\, and validated in follow-up experiments in the lab. We will describe h
 ow we utilized 84\,000 tissue Th17 cells profiled during homeostasis and d
 isease to characterize their heterogeneity\, plasticity\, and migration at
  homeostasis and during CNS autoimmunity. We discovered a homeostatic Th17
  cell population\, that is induced by the intestinal microbiota\, is prese
 nt in both lymphoid organs and the intestine\, and expresses IL-17. We dis
 covered that during EAE this homeostatic population gives rise to a pathog
 enic Th17 cell population\, that migrates specifically through the drainin
 g lymph nodes and the spleen to the CNS\, and highly expresses a specific 
 subset of cytokines. \nIn this talk we will emphasize how coupled single-c
 ell RNA-seq and TCR data was used to generate hypotheses regarding cell su
 btype characterization and T cell clonality and migration\, and how such h
 ypotheses were followed-up on experimentally.\n
LOCATION:https://researchseminars.org/talk/ComputationalBiology/3/
END:VEVENT
BEGIN:VEVENT
SUMMARY:John Marioni (EMBL-EBI)
DTSTART:20210503T155500Z
DTEND:20210503T162500Z
DTSTAMP:20260422T212827Z
UID:ComputationalBiology/4
DESCRIPTION:by John Marioni (EMBL-EBI) as part of Computational Biology Sy
 mposium\n\nAbstract: TBA\n
LOCATION:https://researchseminars.org/talk/ComputationalBiology/4/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Uri Alon (Weizmann Institute)
DTSTART:20210503T172500Z
DTEND:20210503T175500Z
DTSTAMP:20260422T212827Z
UID:ComputationalBiology/5
DESCRIPTION:Title: <a href="https://researchseminars.org/talk/Computationa
 lBiology/5/">Design principles of hormone circuits</a>\nby Uri Alon (Weizm
 ann Institute) as part of Computational Biology Symposium\n\nAbstract: TBA
 \n
LOCATION:https://researchseminars.org/talk/ComputationalBiology/5/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Eran Segal (Weizmann Institute)
DTSTART:20210503T180000Z
DTEND:20210503T183000Z
DTSTAMP:20260422T212827Z
UID:ComputationalBiology/6
DESCRIPTION:Title: <a href="https://researchseminars.org/talk/Computationa
 lBiology/6/">Harnessing big data for personalized medicine</a>\nby Eran Se
 gal (Weizmann Institute) as part of Computational Biology Symposium\n\n\nA
 bstract\nThe recent availability of diverse health data resources on large
  cohorts of human individuals presents many challenges and opportunities. 
 I will present our work aimed at developing machine learning algorithms fo
 r predicting future onset of disease and identifying causal drivers of dis
 ease based on nationwide electronic health record data as well as data fro
 m high-throughput omics profiling technologies such as genetics\, microbio
 me\, and metabolomics. Our models provide novel insights into potential dr
 ivers of obesity\, diabetes\, and heart disease\, and identify hundreds of
  novel markers at the microbiome\, metabolite\, and immune system level. O
 verall\, our predictive models can be translated into personalized disease
  prevention and treatment plans\, and to the development of new therapeuti
 c modalities based on metabolites and the microbiome.\n
LOCATION:https://researchseminars.org/talk/ComputationalBiology/6/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Martin Hemberg (Brigham and Women’s Hospital)
DTSTART:20210503T183500Z
DTEND:20210503T190500Z
DTSTAMP:20260422T212827Z
UID:ComputationalBiology/7
DESCRIPTION:Title: <a href="https://researchseminars.org/talk/Computationa
 lBiology/7/">Searching for alien DNA – characterization of sequences tha
 t are not present in the DNA</a>\nby Martin Hemberg (Brigham and Women’s
  Hospital) as part of Computational Biology Symposium\n\n\nAbstract\nNullo
 mers and nullpeptides are short DNA or amino acid sequences that are absen
 t from a genome or proteome\, respectively. One potential cause for their 
 absence could be that they have a detrimental impact on an organism. Here\
 , we identified all possible nullomers and nullpeptides in the genomes and
  proteomes of over thirty species and show that a significant proportion o
 f these sequences are under negative selection. We assign nullomers to dif
 ferent functional categories (coding sequences\, exons\, introns\, 5’UTR
 \, 3’UTR\, regulatory regions and promoters) and show that nullomers fro
 m coding sequences and promoters are most likely to be selected against. S
 imilarly\, we find that regulatory regions and transcription factor bindin
 g sites harbor more mutations resulting in nullomers than expected. Furthe
 r analysis of coding regions also reveals specific pathways where mutation
 s are more likely to result in nullomers or nullpeptides. Utilizing varian
 ts in the human population\, we annotate variant-associated nullomers\, hi
 ghlighting their potential use as DNA ‘fingerprints’.\n
LOCATION:https://researchseminars.org/talk/ComputationalBiology/7/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Elana Fertig (Johns Hopkins)
DTSTART:20210503T191000Z
DTEND:20210503T194000Z
DTSTAMP:20260422T212827Z
UID:ComputationalBiology/8
DESCRIPTION:Title: <a href="https://researchseminars.org/talk/Computationa
 lBiology/8/">Uncovering hidden sources of transcriptional dysregulation ar
 ising from inter- and intra-tumor heterogeneity.</a>\nby Elana Fertig (Joh
 ns Hopkins) as part of Computational Biology Symposium\n\n\nAbstract\nHete
 rogeneity poses a major challenge in translational research. For example\,
  inter-tumor heterogeneity limits the biomarker discovery and intra-tumor 
 heterogeneity enables therapeutic resistance. Moreover\, in some cancers d
 river mutations are insufficient to account for the widespread transcripti
 onal variation responsible for these outcomes. Thus\, new computational to
 ols to model transcriptional variation are essential. To address this we d
 evelop an innovative computational framework\, Expression Variation Analys
 is (EVA)\, to model transcriptional dysregulation in cancer. Briefly\, EVA
  quantifies transcriptional heterogeneity for one set of samples or cells 
 from one phenotype using the expected dissimilarity between pairs of expre
 ssion profiles. U-statistics theory can then quantify the statistical sign
 ificance of the difference in transcriptional heterogeneity between phenot
 ypes. We apply EVA to perform a comprehensive characterization of transcri
 ptional variation in head and neck squamous cell carcinoma (HNSCC). At a p
 athway level\, transcriptional variation in HNSCC tumors is higher than no
 rmal controls. Applying EVA to integrate ChIP-seq data with RNA-seq reveal
 s that these pervasive transcriptional differences occur in enhancers. Sim
 ilarly\, applying EVA at a gene level to model splicing reveals more heter
 ogeneity in transcript usage in tumor samples than normals. HPV- HNSCC tum
 ors are unique in having mutations in genes that regulate the splicing mac
 hinery\, and the HPV- tumors with these alterations have a greater number 
 of dysregulated splice variants than those without. Nonetheless\, the EVA 
 analysis identifies a similar number of alternative splice variants in HPV
 + as HPV- tumors suggesting an alternative mechanism of transcriptional he
 terogeneity in HPV+ disease. Adapting EVA to single cell data demonstrates
  that increased fibroblast composition is associated with greater variatio
 n in immune pathway activity in HNSCC. Moreover\, we observe greater trans
 criptional heterogeneity in HNSCC primary tumors than lymph node metastasi
 s consistent with a clonal outgrowth. We demonstrate that the statistical 
 framework from EVA enables differential heterogeneity analysis in HNSCC ra
 nging from pathway dysregulation\, splice variation\, epigenetic regulatio
 n\, and single cell analysis. This algorithm provides a critical framework
  to model the hidden multi-molecular mechanisms underlying the complex pat
 ient outcomes that are pervasive in cancer.\n
LOCATION:https://researchseminars.org/talk/ComputationalBiology/8/
END:VEVENT
END:VCALENDAR
